To test whether Lgr6+ cells can act as mammary tumor-initiating cells, the researchers inactivated the two most common mutant breast tumor suppressors, Brca1 and Trp53, in Lgr6+ cells. The gene discussed is LGR6; the disease is breast neoplasm.